The London Clinic, a non-public hospital and charity on London’s Harley Road, has handled its first affected person with Lutetium-177 PSMA remedy, a molecular radiotherapy remedy that targets and kills most cancers cells exactly, minimising harm to wholesome cells and tissue.
Lutetium-177 PSMA is used to deal with superior prostate most cancers that has unfold from the prostate to different components of the physique (also called metastatic prostate most cancers).
The London Clinic’s specialists inject the medicine
into the affected person’s bloodstream. It seeks out tumour cells and binds to them,
delivering a excessive dose of radiation exactly to destroy most cancers cells.
Outcomes from a small variety of medical research for
Lutetium-177 PSMA remedy present that it reduces prostate particular antigen (PSA)
in as much as 70% of sufferers.
The remedy has just lately grow to be out there privately in
the UK.
Professor Val Lewington, nuclear medication specialist at
The London Clinic, stated early medical knowledge for Lutetium-177 PSMA reveals that it
is each efficient and effectively tolerated, so he's optimistic it's going to make an actual
distinction to sufferers and their households.
Satya Bhattacharya, medical director of The
London Clinic, added: “The London Clinic is a pioneering hospital and we're
proud to be ready to supply this innovate prostate most cancers remedy to
our sufferers within the UK and from abroad.”
Post a Comment